Acquisitions, Specialty and Brand Inflation Drive Pharmerica's (PMC) 3Q Beat; Cowen Reiterates Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Dow tick higher as investors weigh Mideast negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Pharmerica (PMC) Tops Q3 EPS by 3c
November 6, 2015 9:17 AM ESTPharmerica (NYSE: PMC) reported Q3 EPS of $0.39, $0.03 better than the analyst estimate of $0.36. Revenue for the quarter came in at $498.8 million versus the consensus estimate of $480.35 million.
For earnings history and earnings-related data on Pharmerica (PMC) click here.
... MoreUPDATE: Trading Radar for 11/6: ArcelorMittal (MT), Cigna (CI), Scripps (SSP), Titan Int'l (TWI) Report
November 5, 2015 3:28 PM EST(Updated - November 5, 2015 3:28 PM EST)
The Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Economics:
8:30am EST
Earnings:
Aeterna Zentaris (Nasdaq: AEZS) - consensus loss $0.06
Ameren Corp (NYSE: AEE) - consensus EPS $1.30
Aratana Therapeutics... More

